Personalized Medicine for Advanced Biliary Cancer Patients

To join the first part of this study, you usually need to be 18 or older and have been diagnosed with an advanced bile duct or gallbladder cancer that can't be removed with surgery or has spread. Your doctors will also check if you're well enough to participate and can have the standard first-line chemotherapy. They'll also need a sample of your tumour tissue to look at its genetic makeup.

There are also some reasons why you might not be able to join. For example, if you've already had a lot of cancer treatment for your advanced disease, or if you have certain other health conditions that would make taking part unsafe. Being pregnant or breastfeeding would also mean you couldn't participate. Your doctor will carefully review all your health information to see if this study is right for you.

If you decide to take part, the study happens in two stages. First, your doctors will take a sample of your tumour (if they don’t have one already) and some blood. They will test these samples to find out if your cancer has any specific genetic changes that could be targeted by special drugs in this study. This is called the 'screening phase'.

If your cancer has these changes and if your initial four cycles of standard chemotherapy are working well without too many side effects, you might be invited to the second stage. In this stage, you would be randomly assigned (like flipping a coin, but with a pre-set chance) to one of two groups: two out of three people would receive a targeted drug matched to your cancer, and one out of three would continue with the standard chemotherapy. You wouldn't get to choose which group you're in, and neither would your doctor. You would have regular visits and assessments to see how you're responding to treatment and to monitor for any side effects. The total length of your participation would depend on how your treatment progresses, and regular follow-up would continue.